Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -20 | -6 | 50 | -43 | -19 |
| Other Working Capital | -387 | 649 | -769 | 1,151 | 1,943 |
| Other Operating Activity | -1,750 | -1,519 | -1,705 | -2,648 | -6,004 |
| Operating Cash Flow | $-2,157 | $-876 | $-2,424 | $-1,539 | $-4,080 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 38 | 38 | 38 | 38 | 38 |
| Debt Repayment | -38 | -38 | -38 | -38 | -38 |
| Common Stock Issued | 4,102 | 0 | 95 | 376 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -208 | 68 |
| Financing Cash Flow | $4,102 | $0 | $95 | $168 | $68 |
| Beginning Cash Position | 710 | 1,586 | 3,916 | 5,287 | 9,299 |
| End Cash Position | 2,655 | 710 | 1,586 | 3,916 | 5,287 |
| Net Cash Flow | $1,945 | $-876 | $-2,329 | $-1,371 | $-4,012 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,157 | -876 | -2,424 | -1,539 | -4,080 |
| Free Cash Flow | -2,157 | -876 | -2,424 | -1,539 | -4,080 |